Basic Information
JANUVIA
50090-4087
Regulatory Information
50090-4087
NDA021995
C73594
July 22, 2022
USA
These highlights do not include all the information needed to use JANUVIA safely and effectively. See full prescribing information for JANUVIA. JANUVIA (sitagliptin) tablets, for oral useInitial U.S. Approval: 2006
HUMAN PRESCRIPTION DRUG LABEL
5
Company Information
830016429
Active Ingredients
ANHYDROUS DIBASIC CALCIUM PHOSPHATE
Code: L11K75P92J
Class Code: IACT
CROSCARMELLOSE SODIUM
Code: M28OL1HH48
Class Code: IACT
MAGNESIUM STEARATE
Code: 70097M6I30
Class Code: IACT
MICROCRYSTALLINE CELLULOSE
Code: OP1R32D61U
Class Code: IACT
POLYETHYLENE GLYCOL, UNSPECIFIED
Code: 3WJQ0SDW1A
Class Code: IACT
POLYVINYL ALCOHOL, UNSPECIFIED
Code: 532B59J990
Class Code: IACT
FERRIC OXIDE RED
Code: 1K09F3G675
Class Code: IACT
SODIUM STEARYL FUMARATE
Code: 7CV7WJK4UI
Class Code: IACT
talc
Code: 7SEV7J4R1U
Class Code: IACT
FERRIC OXIDE YELLOW
Code: EX438O2MRT
Class Code: IACT
titanium dioxide
Code: 15FIX9V2JP
Class Code: IACT
Active Moieties
SITAGLIPTIN
Code: QFP0P1DV7Z